Epigenetic Control of Mammalian Cardiomyocyte Proliferation

Area of Science:

• Cardiovascular Biology
• Epigenetics
• Regenerative Medicine

Background:

• Mammalian cardiomyocyte cell cycle shutdown postnatally limits adult heart regeneration.
• An epigenetic program dictates the transition from proliferation to maturity at birth.
• Understanding this switch offers therapeutic targets for cardiac repair.

Purpose of the Study:

• To review the molecular mechanisms regulating the switch from cardiomyocyte proliferation to cell cycle arrest.
• To explore how epigenetic modifications control this transition and impact heart regeneration.
• To discuss therapeutic strategies for reactivating cardiomyocyte proliferation.

Main Methods:

• Genome-wide analyses of histone modifications and DNA methylation in adult cardiomyocytes.
• Investigation of epigenetic regulation of key transcriptional pathways (YAP, WNT, Notch).
• Review of studies on metabolic reprogramming (glycolysis, oxidative metabolism) and gene therapy for cardiac repair.

Main Results:

• Epigenetic remodeling downregulates cell cycle genes and upregulates maturation genes in adult cardiomyocytes.
• Epigenetic control of YAP, WNT, and Notch pathways prevents adult cardiomyocyte proliferation.
• Metabolic shifts (increased glycolysis) and gene therapy (YAP upregulation) show promise for cardiac repair.
• Adult cardiomyocytes possess structural and metabolic barriers to proliferation.

Conclusions:

• Epigenetic mechanisms are central to suppressing cardiomyocyte proliferation postnatally.
• Targeting epigenetic, metabolic, and structural barriers can potentially restore cardiomyocyte proliferation.
• Reactivating proliferation faces challenges due to the interplay between cell cycle control, epigenetics, metabolism, and cardiac function.